Suchergebnisse - "File, Thomas"

The author file: Thomas Knöpfel.

Autoren: Baker M

Quelle: Nature methods [Nat Methods] 2010 Aug; Vol. 7 (8), pp. 571.

Publikationsart: Biography; Historical Article; Journal Article

Info zur Zeitschrift: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101215604 Publication Model: Print Cited Medium: Internet ISSN: 1548-7105 (Electronic) Linking ISSN: 15487091 NLM ISO Abbreviation: Nat Methods Subsets: MEDLINE

MeSH-Schlagworte: Electrophysiological Phenomena* , Molecular Probe Techniques* , Voltage-Sensitive Dye Imaging*, Brain/*physiology, Animals ; Fluorescent Dyes ; History, 20th Century ; History, 21st Century ; Mice ; Proteins

The author file: Thomas Clandinin.

Autoren: Baker, Monya

Quelle: Nature Methods. Mar2011, Vol. 8 Issue 3, p187-187. 1p. 1 Color Photograph.

Schlagwörter: *FLIES, *GENES, *TRANSCRIPTION factors, *GENETIC transcription

People: CLANDININ, Thomas

New Perspectives on Antimicrobial Agents: Omadacycline for community-acquired pneumonia, skin and soft tissue infections, and nontuberculous mycobacteria (focus on M. abscessus )

Autoren: File, Thomas M. Ramirez, Julio A. Wilde, Ashley M. et al.

Weitere Verfasser: File, Thomas M. Ramirez, Julio A. Wilde, Ashley M. et al.

Quelle: Antimicrobial Agents and Chemotherapy ; volume 69, issue 2 ; ISSN 0066-4804 1098-6596

Verfügbarkeit: https://doi.org/10.1128/aac.01087-24
https://journals.asm.org/doi/pdf/10.1128/aac.01087-24

MASS cohort: Multicenter, longitudinal, and prospective study of the role of microbiome in severe pneumonia and host susceptibility.

Autoren: Wei, Xin Guo, Li Cai, Hongliu et al.

Quelle: iMeta; Aug2024, Vol. 3 Issue 4, p1-7, 7p

Schlagwörter: POSITIVE end-expiratory pressure, ADULT respiratory distress syndrome, MEDICAL personnel, VENTILATOR-associated pneumonia, EMERGING infectious diseases, ENTEROTYPES, PNEUMONIA-related mortality

Next-Generation Sequencing in Periprosthetic Joint Infections: Clinicians' Guide to Its Diagnostic Role.

Autoren: Kullar, Ravina Tipton, Craig D. File, Thomas et al.

Quelle: Infectious Diseases in Clinical Practice; May2025, Vol. 33 Issue 3, p1-8, 8p

How to assess survival prognosis in patients hospitalized for community-acquired pneumonia in 2024?

Autoren: Ramirez, Julio A. File, Thomas M.

Quelle: Current Opinion in Critical Care; Oct2024, Vol. 30 Issue 5, p399-405, 7p

Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults.

Autoren: Isturiz, Raul Grant, Lindsay Gray, Sharon et al.

Quelle: Clinical Infectious Diseases; 10/1/2021, Vol. 73 Issue 7, p1216-1222, 7p

Schlagwörter: STREPTOCOCCAL disease prevention, PNEUMOCOCCAL vaccines, BACTERIAL antigens, SEROTYPES, STREPTOCOCCUS, HOSPITAL care, COMMUNITY-acquired pneumonia, LONGITUDINAL method

Geografische Kategorien: UNITED States

Safety and efficacy of omadacycline for treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in patients with mild-to-moderate renal impairment

Autoren: Cornely, Oliver A. File, Thomas M., Jr. Garrity-Ryan, Lynne et al.

Index Begriffe: ddc:no, doc-type:article, publishedVersion

URL: https://kups.ub.uni-koeln.de/58599/
https://kups.ub.uni-koeln.de/58599
10.1016/j.ijantimicag.2020.106263

663. Efficacy and Safety of Lefamulin (LEF) vs. Moxifloxacin (MOX) for Legionella pneumophila (LP) in Patients with Community-Acquired Bacterial Pneumonia (CABP): Pooled Results From the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Phase 3 Clinical Trials

Autoren: Shorr, Andrew F Schranz, Jennifer Goldberg, Lisa et al.

Quelle: Open Forum Infectious Diseases; 2019 Supplement, Vol. 6, pS303-S304, 2p

Schlagwörter: FLUORESCENT antibody technique, LEGIONELLA pneumophila, COMMUNITY-acquired pneumonia, MOXIFLOXACIN, PNEUMONIA

Erratum to: Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial.

Autoren: File, Thomas M Goldberg, Lisa Das, Anita et al.

Quelle: Clinical Infectious Diseases; Jun2020, Vol. 70 Issue 11, p2459-2459, 1p

Schlagwörter: PATIENT safety, PNEUMONIA, COMMUNITY-acquired pneumonia

RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections.

Autoren: Motsch, Johann Oliveira, Cláudia Murta de Stus, Viktor et al.

Quelle: Clinical Infectious Diseases; 5/1/2020, Vol. 70 Issue 9, p1799-1808, 10p

Schlagwörter: ANTIBIOTICS, CONFIDENCE intervals, DRUG side effects, ENTEROBACTERIACEAE, ENZYME inhibitors, GRAM-negative bacterial diseases, KLEBSIELLA, MEDICAL cooperation, NEPHROTOXICOLOGY, RESEARCH, STATISTICAL sampling, RANDOMIZED controlled trials, TREATMENT effectiveness, BLIND experiment, DESCRIPTIVE statistics, COLISTIN, IMIPENEM

664. Efficacy in Adults With Moderate to Severe Community-Acquired Bacterial Pneumonia (CABP) and Pneumonia Outcomes Research Team (PORT) Risk Class III to V: Results of a Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Outcomes

Autoren: Alexander, Elizabeth Schranz, Jennifer Das, Anita F et al.

Quelle: Open Forum Infectious Diseases; 2019 Supplement, Vol. 6, pS304-S305, 2p

Schlagwörter: RESEARCH teams, PNEUMONIA, ADULTS, COMORBIDITY, MEDICAL research personnel

Firma/Körperschaft: UNITED States. Food & Drug Administration

2233. Efficacy and Symptom Resolution by Visit in Adults With Community-Acquired Bacterial Pneumonia (CABP) Treated With Lefamulin (LEF) or Moxifloxacin (MOX): Pooled Analysis of Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 Study Results.

Autoren: Schranz, Jennifer Das, Anita F Alexander, Elizabeth et al.

Quelle: Open Forum Infectious Diseases; 2019 Supplement, Vol. 6, pS762-S763, 2p

Schlagwörter: COMMUNITY-acquired pneumonia, MOXIFLOXACIN, ADULTS

Firma/Körperschaft: UNITED States. Food & Drug Administration

Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases of America Strategic Plan.

Autoren: Sears, Cynthia L File, Thomas M Alexander, Barbara D et al.

Quelle: Clinical Infectious Diseases; 12/15/2019, Vol. 69 Issue 12, pe1-e7, 7p

Schlagwörter: COMMUNICABLE diseases, COMMUNICATION, DRUG resistance in microorganisms, LABOR supply, MEDICAL quality control, MEDICAL protocols, ORGANIZATIONAL change, QUALITY assurance, STRATEGIC planning, PROFESSIONALISM, CHANGE management, HUMAN services programs, ORGANIZATIONAL goals

Geografische Kategorien: UNITED States

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza a.

Autoren: Uyeki, Timothy M Fry, Alicia M Ison, Michael G et al.

Quelle: Clinical Infectious Diseases; 3/15/2019, Vol. 68 Issue 6, p895-902, 8p

Schlagwörter: CHEMOPREVENTION, DISEASE outbreaks, MEDICAL protocols, DISEASE management, SEASONAL influenza, DIAGNOSIS, THERAPEUTICS

Geografische Kategorien: UNITED States

Risk variants and polygenic architecture of disruptive behavior disorders in the context of attention-deficit/hyperactivity disorder.

Autoren: Demontis, Ditte Walters, Raymond K. Rajagopal, Veera M. et al.

Quelle: Nature Communications; 1/25/2021, Vol. 12 Issue 1, p1-12, 12p

Schlagwörter: BEHAVIOR disorders, ATTENTION-deficit hyperactivity disorder, GENETIC correlations, AGGRESSION (Psychology), MENTAL illness, COMORBIDITY

Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-acquired Bacterial Pneumonia.

Autoren: Watkins, Richard R File, Thomas M

Quelle: Clinical Infectious Diseases; 11/15/2020, Vol. 71 Issue 10, p2757-2762, 6p

Schlagwörter: ANTIBIOTICS, MUSCLE protein metabolism, DRUG resistance in microorganisms, ENZYME inhibitors, COMMUNITY-acquired pneumonia, TREATMENT effectiveness, PHARMACODYNAMICS

Pathways to Leadership: Reflections of Recent Infectious Diseases Society of America (IDSA) Leaders During Conception and Launch of the Inclusion, Diversity, Access, and Equity Movement Within the IDSA.

Autoren: Sears, Cynthia L Powderly, William G Auwaerter, Paul G et al.

Quelle: Journal of Infectious Diseases; 2020 Supplement, Vol. 222, pS554-S559, 6p

Schlagwörter: COMMUNICABLE diseases, LEADERSHIP, CONCEPTION, CAREER development, DIVERSITY & inclusion policies

Firma/Körperschaft: INFECTIOUS Diseases Society of America

Treatment of Community-Acquired Pneumonia in Immunocompromised Adults

Autoren: Ramirez, Julio A. Musher, Daniel M. Evans, Scott E. et al.

Weitere Verfasser: Ramirez, Julio A. Musher, Daniel M. Evans, Scott E. et al.

Quelle: Author

Schlagwörter: community-acquired pneumonia, immunocompromised, pneumonia

Dateibeschreibung: application/pdf

Relation: Chest; https://hdl.handle.net/1805/23738

Verfügbarkeit: https://hdl.handle.net/1805/23738

Antibiotic Development Incentives That Reflect Societal Value of Antibiotics.

Autoren: Boucher, Helen W File, Thomas M Fowler, Vance G et al.

Quelle: Clinical Infectious Diseases; 5/1/2021, Vol. 72 Issue 9, pe420-e421, 2p

Schlagwörter: DRUGS & economics, DRUG laws, SOCIAL values, COST analysis, GENERIC drugs, ANTIBIOTICS

Geografische Kategorien: UNITED States

Firma/Körperschaft: UNITED States. Food & Drug Administration